Reengineering Ponatinib to Minimize Cardiovascular Toxicity

Overview of attention for article published in Cancer Research, May 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 7 X users

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Wikipedia Dimensions citations

So far, Altmetric has seen 1 Wikipedia article.

English

Ponatinib

Cited by user 171.66.12.126 on 09 Aug 2022

Ponatinib (trade name Iclusig, previously AP24534) is an oral drug developed by ARIAD Pharmaceuticals for the treatment of chronic myeloid leukemia (CML) and…

This page shows the most recent Wikipedia articles that mention this research output.

Click here to find out how to access more activity.